Clearmind Medicine (CMND) plans to conduct a reverse share split of its issued and outstanding common shares at a ratio of 1-for-10 as part of a plan to regain compliance with the Nasdaq Minimum Bid Price Rule. – The split will be effective from May 21, 2026, and will adjust…
e number of issued and outstanding common shares from 10,190,337 to ~1,019,033. – CMND shares fell -20% premarket